Literature DB >> 3817030

Laser-induced glaucoma in rabbits.

T Gherezghiher, W F March, R E Nordquist, M C Koss.   

Abstract

Argon laser energy was applied to the trabecular meshwork of pigmented rabbits in an attempt to develop an animal model of 'glaucoma'. Laser energy was varied to determine the optimal level needed to produce sustained ocular hypertension. An initial response of ocular hypertension followed by hypotension was observed in all of the animals tested. Approximately half of the laser-treated rabbits developed a secondary buphthalmus and sustained ocular hypertension. In these animals outflow facility was decreased by approximately 60%. Histologic examination at 4- and 8 weeks after laser treatment demonstrated a wound-healing response resulting in closure of the intertrabecular spaces and obstruction of outflow to injected carbon particles. Optic nerve cupping and a loss of ganglion cells were also observed. Topical application of L-timolol (0.5%), pilocarpine (2.0%) and forskolin (1.0%) were found to be effective in decreasing intraocular pressure in the laser-treated, hypertensive eye with no significant effect in control non-laser-treated eyes, suggesting that this model can be a useful tool for screening potential antiglaucoma medications.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3817030     DOI: 10.1016/0014-4835(86)90067-9

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  11 in total

1.  [New concepts for pressure-controlled glaucoma implants].

Authors:  R Allemann; O Stachs; K Falke; W Schmidt; S Siewert; K Sternberg; B Chichkov; A Wree; K-P Schmitz; R F Guthoff
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

2.  Outflow facility and extent of angle closure in a porcine model.

Authors:  Ying Hong; Chao Wang; Ralitsa Loewen; Susannah Waxman; Priyal Shah; Si Chen; Hamed Esfandiari; Nils A Loewen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-04-03       Impact factor: 3.117

3.  Optic neuropathy and increased retinal glial fibrillary acidic protein due to microbead-induced ocular hypertension in the rabbit.

Authors:  Jun Zhao; Tian-Hui Zhu; Wen-Chieh Chen; Shi-Ming Peng; Xiao-Sheng Huang; Kin-Sang Cho; Dong Feng Chen; Guei-Sheung Liu
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

Review 4.  Could adverse effects and complications of selective laser trabeculoplasty be decreased by low-power laser therapy?

Authors:  Alexandre de Carvalho Mendes Paiva; Adenilson de Souza da Fonseca
Journal:  Int Ophthalmol       Date:  2017-11-30       Impact factor: 2.031

5.  Effect of intracameral human cord blood-derived stem cells on lasered rabbit trabecular meshwork.

Authors:  Ramanjit Sihota; Seema Sen; Sujata Mohanty; Mohammad Ahmad; Alok Ravi; Viney Gupta; Neerja Bhatla
Journal:  Int Ophthalmol       Date:  2019-05-28       Impact factor: 2.031

6.  Antagonism of muscarinic receptors in the rabbit iris-ciliary body by 8-OH-DPAT and other 5-HT1A receptor agonists.

Authors:  G Chidlow; N N Osborne
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Vascular changes in the posterior eye segment of secondary angle-closure glaucoma: cause or consequence?

Authors:  Christian Albrecht May; Thom Mittag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-21       Impact factor: 3.117

Review 8.  Animal models of glaucoma.

Authors:  Rachida A Bouhenni; Jeffrey Dunmire; Abby Sewell; Deepak P Edward
Journal:  J Biomed Biotechnol       Date:  2012-05-15

Review 9.  Experimentally Induced Mammalian Models of Glaucoma.

Authors:  Makoto Ishikawa; Takeshi Yoshitomi; Charles F Zorumski; Yukitoshi Izumi
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

10.  Strain Specific Responses in a Microbead Rat Model of Experimental Glaucoma.

Authors:  Karen Eastlake; Hari Jayaram; Joshua Luis; Matthew Hayes; Peng T Khaw; G Astrid Limb
Journal:  Curr Eye Res       Date:  2020-08-25       Impact factor: 2.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.